Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
Clinical Research and Public Health
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Video Abstracts
Reviews
Reviews
View all reviews ...
Review Series
Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
Pancreatic Cancer (Jul 2025)
Complement Biology and Therapeutics (May 2025)
Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
Microbiome in Health and Disease (Feb 2025)
Substance Use Disorders (Oct 2024)
Clonal Hematopoiesis (Oct 2024)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Editor's notes
Reviews
Viewpoints
100th anniversary
Top read articles
Conversations With Giants In Medicine
80 Articles
80 Posts
← Previous
1
2
3
…
7
8
Next →
Ending one conversation, starting another
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
Ending one conversation, starting another
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Zhijian (James) Chen
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Zhijian (James) Chen
Text
PDF
Abstract
Authors
Ushma S. Neill
×
Conversations with JCI editors in chief
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
Conversations with JCI editors in chief
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Stanley Prusiner
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Stanley Prusiner
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Elias Zerhouni
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Elias Zerhouni
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Olufunmilayo Olopade
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Olufunmilayo Olopade
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Peter Hotez
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Peter Hotez
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Elizabeth Jaffee
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Elizabeth Jaffee
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Katherine High
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Katherine High
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Jeffrey Whitsett
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Jeffrey Whitsett
Text
PDF
Abstract
Authors
Ushma S. Neill
×
← Previous
1
2
3
…
7
8
Next →
← Previous
1
2
3
4
…
7
8
Next →
JCI's Conversations with Giants in Medicine: Jesse Roth
We take it for granted today that each hormone and other intercellular messenger have their own specific receptors. But this was not the case until the groundbreaking work of Jesse Roth and his colleagues.
Published July 1, 2020
Conversations with Giants in Medicine
Conversations with Giants in Medicine: Barbara Kahn
Dr. Kahn is best known for elucidating the molecular mechanisms of type 2 diabetes, obesity, and insulin resistance.
Published March 2, 2020
Conversations with Giants in Medicine
JCI's Conversations with Giants in Medicine: Marc Feldmann, Jacques Miller, and Max Cooper
Sir Marc Feldmann, Lasker awardee in 2003 for his role in discovering anti-TNF therapy, acts as interviewer, speaking with the two recipients of the 2019 Albert Lasker Basic Medical Research Award.
Published January 2, 2020
Conversations with Giants in Medicine
JCI's Conversations with Giants in Medicine: Elaine Fuchs
Cell biologist Elaine Fuchs of the Rockefeller University is best known for revolutionizing the molecular and genetic study of skin.
Published November 1, 2019
Conversations with Giants in Medicine
JCI's Conversations with Giants in Medicine: Lucy Shapiro
Lucy Shapiro's insights helped launch the field of systems biology, and more recently, her work has led to the development of novel antifungal drugs.
Published August 1, 2019
Conversations with Giants in Medicine
JCI's Conversations with Giants in Medicine: George Church
The geneticist, innovator, and entrepreneur George Church, of Harvard and MIT, developed the methods for the first genome sequencing,
Published April 1, 2019
Conversations with Giants in Medicine
Carla Shatz
Neurobiologist Carla Shatz, director of Stanford University Bio-X, has focused her research on how early brain circuits are transformed into adult connections during critical periods of development.
Published October 1, 2018
Conversations with Giants in Medicine
JCI’s Conversations with Giants in Medicine: Cornelia Bargmann
Cornelia Bargmann of Rockefeller University and the Chan Zuckerberg Initiative explores the intersection between genes, the environment, and the nervous system.
Published July 2, 2018
Conversations with Giants in Medicine
Charles Sawyers
Charles Sawyers of Memorial Sloan Kettering Cancer Center has defined the molecular lesions that cause cancer and used these insights to develop new drugs.
Published April 2, 2018
Conversations with Giants in Medicine
JCI’s Conversations with Giants in Medicine: Douglas R. Lowy and John T. Schiller
The combined efforts of Doug Lowy and John Schiller form the basis of the biology behind the vaccines for HPV.
Published January 2, 2018
Conversations with Giants in Medicine
← Previous
1
2
3
4
…
7
8
Next →
Advertisement
